AIG
CGEM icon

American International Group’s Cullinan Oncology CGEM Stock Holding History

American International Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,742
Closed -$217K – 515
2024
Q1 		$217K Sell
12,742
-1,223,822
-99% -$18.9M ﹤0.01% 2099
2023
Q4 		$12.6M Buy
1,236,564
+972
+0.1% +$8.61K 0.05% 272
2023
Q3 		$11.2M Buy
1,235,592
+423
+0% +$4.41K 0.07% 296
2023
Q2 		$13.3M Sell
1,235,169
-1,180
-0.1% -$12.5K 0.08% 239
2023
Q1 		$12.6M Sell
1,236,349
-1,729
-0.1% -$19.1K 0.08% 250
2022
Q4 		$13.1M Sell
1,238,078
-53
-0% -$644 0.09% 224
2022
Q3 		$15.9M Buy
1,238,131
+463
+0% +$6.24K 0.12% 150
2022
Q2 		$15.9M Buy
1,237,668
+1,108
+0.1% +$12.6K 0.11% 163
2022
Q1 		$12.9M Sell
1,236,560
-904
-0.1% -$12.2K 0.07% 313
2021
Q4 		$19.1M Sell
1,237,464
-413
-0% -$8.24K 0.1% 188
2021
Q3 		$27.9M Buy
1,237,877
+6,756
+0.5% +$181K 0.15% 108
2021
Q2 		$31.7M Buy
1,231,121
+1,223,471
+15,993% +$37.6M 0.11% 143
2021
Q1 		$319K Buy
+7,650
New +$311K ﹤0.01% 2097

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American International Group's CGEM Position: Q2 2024 in Review

American International Group sold out of Cullinan Oncology (CGEM) in Q2 2024, closing a stake of 12,742 shares — an estimated $217K sold.

American International Group first reported a position in CGEM in Q1 2021 and held it in 13 quarters. The position peaked at $31.7M in Q2 2021. 135 funds tracked by Wall St. Rank hold CGEM as of Q2 2024.

  • American International Group reported no remaining Cullinan Oncology position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 12,742 Cullinan Oncology shares in Q2 2024, an estimated $217K.
  • American International Group first reported a position in Cullinan Oncology in Q1 2021 and held it in 13 quarters.
  • American International Group's Cullinan Oncology position peaked at $31.7M in Q2 2021.
  • 135 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.